RG

Rengu George Joseph

Director Director DIN 02050704
DIN 02050704 First appointment Feb 2008 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Feb 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Rengu George Joseph

Data last updated:

Rengu George Joseph has 18 years in corporate governance. Formerly with 1 company, such as Clinipace Clinical Research Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02050704
Primary Designation Director
First Appointment 01 Feb 2008
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alternate Director01 Feb 20082003₹42.52 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Clinipace Clinical Research Private Limited
Premium access

Shareholding and investment profile for Rengu George Joseph

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rengu George Joseph

Rengu George Joseph has 18 years in corporate governance. Formerly with 1 company, such as Clinipace Clinical Research Private Limited. Engaged in General Business. Contributes to corporate operations.

Rengu George Joseph has expertise in General Business.

Rengu George Joseph has 18 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available